CPHINYSEManufacturing

China Pharma Holdings, Inc. (CPHI) earnings date, market-implied expected move, and options open interest by expiry

0.62

−0.01 · −1.28%

Regular session15:13 ET

Open0.64Volume184,285Mkt cap$26.9MEPS-0.11

Day0.61 – 0.6425%52-wk0.38 – 19.191%

CPHI

China Pharma Holdings, Inc.

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

No implied move.

Next report

Nov 13

in 11 days

est.Q3 FY26

Calendar

Next report

Last report

—

Largest filed tie

filed ties

13F top-10 QoQ

—

Top fund weight

—

China Pharma (CPHI) is expected to report on Nov 13 (estimated date).

Implied vs realized

No reported quarters.

Implied vs realized

Positioning

No open-interest data.

Positioning

Linked exposure

No linked exposure.

Linked exposure

Revenue flow

as filedQ2 FY26

−153.76%as filednet margin · revenue −3.58% QoQ · −7.55% YoY

Revenue$948,340−3.58%

Gross profit$83,5668.81%−70.73%

Operating income−$1M−150.98%−28.16%

Pre-tax income−$1M−27.55%

Net income−$1M−153.76%−27.55%

Cost of revenue$864,774+23.88%

Operating expenses$2M+8.03%

Tax$0—

Other expense−$26,278−1.52%

Source: SEC filings · standardized · QE Jun 30 '26 · bars = % of revenue

Revenue flow

Intraday

15m bars

Hatch = extended hours · ▯ up · ▮ downSource: market data · 17:15 ET

Intraday

Event sensitivity

PPI ×1.97· ±11.3% vs ±5.8% · 11 releases

eventrelease day|move|up · n×base

PPIproducer prices±11.3%4 of 11×1.97

CPIconsumer prices±9.4%6 of 10×1.64

GDPgross domestic product±5.5%12 of 20×0.96

PCEpersonal income & outlays±5.5%9 of 20×0.95

NFPjobs report±4.8%3 of 10×0.84

CPROFcorporate profits±4.2%8 of 12×0.73

FOMCrate decision±3.3%8 of 24×0.57

Bar = avg |move| to ±12% · tick = ±5.8% avg day · ×base = |move| ÷ ±5.8% · min 6 releases

Earnings history

EPS -0.04 · consensus —

Quarter	Reported	EPS	Consensus
Q2 FY26	—	-0.04	—
Q1 FY26	—	-0.04	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod